Welcome to LookChem.com Sign In|Join Free

CAS

  • or

150767-00-3

Post Buying Request

150767-00-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

150767-00-3 Usage

Description

Tert-butyl 2-(4-Methoxybenzylidene)hydrazinecarboxylate is a hydrazine derivative with the molecular formula C14H20N2O3. It is a chemical compound that has gained attention in the pharmaceutical industry due to its potential as an anticancer agent, metalloproteinase inhibitor, and its possible applications as an antiviral and antifungal agent. The presence of the tert-butyl group enhances its stability and solubility, making it a promising candidate for drug development.

Uses

Used in Pharmaceutical Industry:
Tert-butyl 2-(4-Methoxybenzylidene)hydrazinecarboxylate is used as an anticancer agent for its potential to inhibit the growth of cancer cells. It targets various types of cancer and has shown promise in the development of new cancer treatments.
Used in Inflammatory and Autoimmune Disease Treatment:
In the treatment of inflammatory and autoimmune diseases, tert-butyl 2-(4-Methoxybenzylidene)hydrazinecarboxylate is used as a metalloproteinase inhibitor. Its ability to inhibit metalloproteinases can help manage the symptoms and progression of these diseases.
Used in Antiviral Applications:
Tert-butyl 2-(4-Methoxybenzylidene)hydrazinecarboxylate is studied for its potential as an antiviral agent. Its antiviral properties could be utilized in the development of treatments for various viral infections.
Used in Antifungal Applications:
tert-butyl 2-(4-Methoxybenzylidene)hydrazinecarboxylate is also being studied for its potential as an antifungal agent. Its antifungal properties may be harnessed to develop treatments for fungal infections.
Used in Drug Development:
Due to its improved stability and solubility, tert-butyl 2-(4-Methoxybenzylidene)hydrazinecarboxylate is used as a promising candidate for further drug development. Its versatility in various applications makes it a valuable compound for research and development in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 150767-00-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,7,6 and 7 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 150767-00:
(8*1)+(7*5)+(6*0)+(5*7)+(4*6)+(3*7)+(2*0)+(1*0)=123
123 % 10 = 3
So 150767-00-3 is a valid CAS Registry Number.

150767-00-3Relevant articles and documents

Gold-catalyzed three-component spirocyclization: A one-pot approach to functionalized pyrazolidines

Wagner, Bernd,Hiller, Wolf,Ohno, Hiroaki,Krause, Norbert

, p. 1579 - 1583 (2016/02/10)

An efficient, highly atom economic synthesis of hitherto unknown spirocyclic pyrazolidines in a one-pot process was developed. The gold-catalyzed three-component coupling of alkynols, hydrazines and aldehydes or ketones likely proceeds via cycloisomerization of the alkynol to an exocyclic enol ether and subsequent [3 + 2]-cycloaddition of an azomethine ylide. A library of 29 derivatives with a wide range of functional groups was synthesized in up to 97% yield. With this new method, every position in the final product can be substituted which renders the method ideal for applications in combinatorial or medicinal chemistry.

Synthesis and biological evaluation of Hydrazone derivatives as antifungal agents

Casanova, Bruna B.,Muniz, Mauro N.,De Oliveira, Thayse,De Oliveira, Luís Flavio,Machado, Michel M.,Fuentefria, Alexandre M.,Gosmann, Grace,Gnoatto, Simone C. B.

, p. 9229 - 9241 (2016/08/31)

Emerging yeasts are among the most prevalent causes of systemic infections with high mortality rates and there is an urgent need to develop specific, effective and non-Toxic antifungal agents to respond to this issue. In this study 35 aldehydes, hydrazones and hydrazines were obtained and their antifungal activity was evaluated against Candida species (C. parapsilosis, C.Tropicalis, C. krusei, C. albicans, C. glabrata and C. lusitaneae) and Trichosporon asahii, in an in vitro screening. The minimum inhibitory concentrations (MICs) of the active compounds in the screening was determined against 10 clinical isolates of C. parapsilosis and 10 of T. asahii. The compounds 4-pyridin-2-ylbenzaldehyde] (13a) and tert-butyl-(2Z)-2-(3,4,5-Trihydroxybenzylidine)hydrazine carboxylate (7b) showed the most promising MIC values in the range of 16-32 μg/mL and 8-16 μg/mL, respectively. The compounds' action on the stability of the cell membrane and cell wall was evaluated, which suggested the action of the compounds on the fungal cell membrane. Cell viability of leukocytes and an alkaline comet assay were performed to evaluate the cytotoxicity. Compound 13a was not cytotoxic at the active concentrations. These results support the discovery of promising candidates for the development of new antifungal agents.

Development and a practical synthesis of the JAK2 inhibitor LY2784544

Mitchell, David,Cole, Kevin P.,Pollock, Patrick M.,Coppert, David M.,Burkholder, Timothy P.,Clayton, Joshua R.

scheme or table, p. 70 - 81 (2012/05/31)

The route selection and process research and development of a practical synthesis for JAK2 inhibitor LY2784544 is described. The first-generation synthesis route, similar to that used in discovery for derivatization of a benzylic amine moiety, was 14 overall steps and possessed several steps that required extensive development for large-scale production. Route selection considerations led to a modified synthesis that utilized a novel vanadium-catalyzed carbon-carbon bond-forming arylation reaction for incorporation of the key benzylic morpholine moiety. A protecting group used to mask an amino pyrazole unit was modified from PMB to tert-butyl, resulting in a dramatic reduction in the overall length of the route. These two major changes resulted in an eight-step synthesis, which was six steps shorter than the first-generation synthesis. In the pilot plant, the new synthesis was scaled to produce >100 kg of LY2784544 in high yield and purity under GMP conditions. The overall development including the vanadium-catalyzed C-C bond-forming methodology, a ketone reductive deoxygenation, and a palladium-catalyzed amination is described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 150767-00-3